Accreditation and Designation User Manual - OECI

More documents

Recommendations

Info

4.3. Resources and materials 4.3.1. Means for conducting research activities Does the cancer centre have the means for conducting its research activities? 4.3.1.1. 4.3.1.1.1. The budget for cancer research is clearly and yearly defined 4.3.1.1.2. The cancer centre provides access to facilities for research activities 4.3.1.1.3. The cancer centre provides resources and means for research activities 4.3.1.1.4. Funding of research activities follows clearly defined procedures 4.3.1.1.5. The use of financial resources and accounting of research activities is controlled, monitored and reported according to rules Yes Mostly Partially No not applicable 4.3.2. Intellectual property and innovation Is there a policy for the protection of intellectual property? 4.3.2.1. 4.3.2.1.1. There is a strategy for innovation 4.3.2.1.2. There is support for protection and exploitation of intellectual property 4.3.2.1.3. There is support for business development of research projects 4.3.2.1.4. There is a technology transfer service available Yes Mostly Partially No not applicable 4.3.3. Biobank 4.3.3.1. 4.3.3.1.1. The cancer centre has a policy for biobanking patient related samples 4.3.3.1.2. There is a SOP defining the collection, the storage, the registration and the use of the biological samples 4.3.3.1.3. There is a centralised registration of the data related to the biological material Yes Mostly Partially No not applicable 20 / OECI Accreditation and Designation / Appendix II
4.4. Process control 4.4.1. Structured scientific programme Is there a structured scientific exchange programme in the cancer centre? (colloquia, seminars, theme-specific conferences). 4.4.1.1. 4.4.1.1.1. There is a structured, documented and up to date scientific programme in the cancer centre through colloquia, seminars or theme-specific conferences. 4.4.1.1.2. Scientific programmes are used to guarantee that results from research will be translated into daily practice timely; (e.g.) diagnostic tools, treatment or prevention Yes Mostly Partially No not applicable 4.4.2. Teaching programme for PhD students Is there a teaching programme for PhD students ? 4.4.2.1. Yes Mostly Partially No not applicable 4.4.2.1.1. There is a teaching programme for PhD students 4.4.3. Transfer of new scientific information to clinical practice Is there a procedure for the transfer of new scientific information to clinical practice? 4.4.3.1. 4.4.3.1.1. There is a procedure that guarantees that results from research will be translated into daily practice timely.(e.g.) diagnostic tools, treatment or prevention) Yes Mostly Partially No not applicable 4.5. Safeguarding the quality system 4.5.1. Periodical site visit/review. Is there a periodical site visit/review of the total research organisation? 4.5.1.1. There is a periodical review and/or site visit, with external reviewers, of: Yes Mostly Partially No not applicable 4.5.1.1.1. the total research organisation 4.5.1.1.2. each research group/team activities 4.5.1.1.3. clinical/translational research 4.5.1.1.4. research support facilities Appendix II / OECI Accreditation and Designation / 21
Page 1:
ORGANISATION OF EUROPEAN CANCER INS
Page 4 and 5:
OECI Accreditation and Designation
Page 6 and 7:
THE OECI Accreditation and Designat
Page 8 and 9:
Owner: OECI Organisation of Europea
Page 10 and 11:
The keyword in the designation of E
Page 12 and 13:
2.1.1 General explanation of the te
Page 14 and 15:
OECI General Assembly Member Instit
Page 16 and 17:
− Organizing the auditors’ meet
Page 18 and 19:
3.2 Audit team and auditors 3.2.1 O
Page 20 and 21:
3.3 Cancer institute Obviously all
Page 22 and 23:
Owner: OECI Organisation of Europea
Page 24 and 25:
5.1.1 Step 1: activities and respon
Page 26 and 27: Designation questionnaire Executor:
Page 28 and 29: Send signed accreditation and desig
Page 30 and 31: 5.3 Step 3: Explanatory visit and p
Page 32 and 33: 5.4.1 Step 4: activities and respon
Page 34 and 35: Finishing self-assesment Executor:
Page 36 and 37: 5.6 Step 6: Payment stage 2 fee If
Page 38 and 39: Preparation of the auditors’ team
Page 40 and 41: Performing the peer review Executor
Page 42 and 43: 5.8.1 Week 1-6: Reporting by the au
Page 44 and 45: 5.8.2 Step 8: activities and respon
Page 46 and 47: 5.9 Step 9: Formulate improvement p
Page 48 and 49: 5.10.1 Evaluation of the A&D Progra
Page 50 and 51: Intermediate self-assessment (optio
Page 52 and 53: Owner: OECI Organisation of Europea
Page 58 and 59: 2 / OECI Accreditation and Designat
Page 60 and 61: Qualitative Questionnaire 1. Genera
Page 62 and 63: 1.3.2. Administration of cytostatic
Page 64 and 65: 1.4.6. Roles and tasks of the membe
Page 66 and 67: 1.4.12. Registration and evaluation
Page 68 and 69: 1.5.5. Quality assurance in all are
Page 70 and 71: 2.4.5. Smoking control in the cance
Page 72 and 73: 3.4.4. Palliative and terminal care
Page 74 and 75: 4. Research, innovation and develop
Page 78 and 79: 5. Teaching and continuing educatio
Page 80 and 81: 6. Patient related 6.4. Process con
Page 82 and 83: 6.5. Safeguarding the quality syste
Page 84 and 85: 1.4.7. at national level at regiona
Page 86 and 87: 2.3. Infrastructures with a focus o
Page 88 and 89: 2.9. Radiology 2.9.1. Number of CT
Page 90 and 91: 2.15. Facilities 2.15.1. On site Ac
Page 92 and 93: 3.4. Human resources (4) 3.4.1. Pat
Page 94 and 95: 4.3. Structures 4.3.1. Yes No not a
Page 96 and 97: 5. Education 5.1. Education 5.1.1.
Page 98 and 99: Planning of the project Start Expla
Page 100 and 101: Go to the qualitative and quantitat
Page 102 and 103: 3. Before moving to the next item p
Page 104 and 105: The following screen will appear. F
Page 106 and 107: • Close the questionnaire if you
Page 108 and 109: Print only the questions or the ful
Page 110 and 111: Workspace: Go to the questionnaires
Page 112 and 113: 2. Preparing a peer review Open a q
Page 114 and 115: To view the remarks and the score o
Page 116 and 117: 2 / OECI Accreditation and Designat
Page 118 and 119: Qualitative Questionnaire 1. Genera
Page 120 and 121: 1.3.2. Administration of cytostatic
Page 122 and 123: 1.4.6. Roles and tasks of the membe
Page 124 and 125: 1.4.12. Registration and evaluation
Page 126 and 127:
1.5.5. Quality assurance in all are
Page 128 and 129:
2.4.5. Smoking control in the cance
Page 130 and 131:
3.4.4. Palliative and terminal care
Page 132 and 133:
4. Research, innovation and develop
Page 134 and 135:
4.3. Resources and materials 4.3.1.
Page 136 and 137:
5. Teaching and continuing educatio
Page 138 and 139:
6. Patient related 6.4. Process con
Page 140 and 141:
6.5. Safeguarding the quality syste
Page 142 and 143:
1.4.7. at national level at regiona
Page 144 and 145:
2.3. Infrastructures with a focus o
Page 146 and 147:
2.9. Radiology 2.9.1. Number of CT
Page 148 and 149:
2.15. Facilities 2.15.1. On site Ac
Page 150 and 151:
3.4. Human resources (4) 3.4.1. Pat
Page 152 and 153:
4.3. Structures 4.3.1. Yes No not a
Page 154 and 155:
5. Education 5.1. Education 5.1.1.
Page 156 and 157:
Planning of the project Start Expla
Page 158 and 159:
Go to the qualitative and quantitat
Page 160 and 161:
3. Before moving to the next item p
Page 162 and 163:
The following screen will appear. F
Page 164 and 165:
• Close the questionnaire if you
Page 166 and 167:
Print only the questions or the ful
Page 168 and 169:
Workspace: Go to the questionnaires
Page 170 and 171:
2. Preparing a peer review Open a q
Page 172:
To view the remarks and the score o
show all

Accreditation and Designation User Manual - OECI

Create successful ePaper yourself

Delete template?

Save as template?